MOPP (oncology)

MOPP (oncology) [r]: A combination regimen, for cancer chemotherapy, of the antineoplastic agents methotrexate, Oncovin (brand of vincristine), procarbazine and prednisone; generally superseded by newer combinations [e]

This article contains just a definition and optionally other subpages (such as a list of related articles), but no metadata. Create the metadata page if you want to expand this into a full article.